Free Trial
CVE:VM

Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

Voyageur Pharmaceuticals logo
C$0.18 +0.01 (+5.88%)
As of 10:50 AM Eastern

About Voyageur Pharmaceuticals Stock (CVE:VM)

Key Stats

Today's Range
C$0.17
C$0.18
50-Day Range
C$0.06
C$0.24
52-Week Range
C$0.04
C$0.25
Volume
40,060 shs
Average Volume
469,370 shs
Market Capitalization
C$25.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

VM Stock News Headlines

Voyageur Pharmaceuticals (CVE:VM) Trading Up 21.2% - Here's What Happened
Voyageur Pharmaceuticals (CVE:VM) Trading Up 21.2% - Still a Buy?
Texas approves new currency
Rural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the global banking system... backed up by Elon Musk and the White House.
Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.2% - Still a Buy?
Canadian Investment Regulatory Organization Trading Halt - VM
See More Headlines

VM Stock Analysis - Frequently Asked Questions

Voyageur Pharmaceuticals' stock was trading at C$0.09 at the start of the year. Since then, VM shares have increased by 111.8% and is now trading at C$0.18.
View the best growth stocks for 2025 here
.

Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Voyageur Pharmaceuticals investors own include GFG Resources (GFG), Pine Cliff Energy (PNE), Tamarack Valley Energy (TVE), Caladrius Biosciences (CLBS), Capstone Copper (CS), Calibre Mining (CXB) and Mawson Gold (MAW).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-1,300,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Book Value
C$0.01 per share

Miscellaneous

Free Float
N/A
Market Cap
C$23.71 million
Optionable
Not Optionable
Beta
0.32
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (CVE:VM) was last updated on 2/5/2025 by MarketBeat.com Staff
From Our Partners